精子形态是否影响正常精子总数和活力不育夫妇中卵胞浆内单精子注射与传统体外受精的选择:一项随机临床试验的二次分析
该研究为一项开放标签多中心随机临床试验的二次分析,纳入1064对精子总数和活力正常的夫妇,比较ICSI与传统IVF。精子形态中位数两组均为3%(IQR 1-6%)。精子形态与治疗效应在活产、持续妊娠、临床妊娠和完全受精失败上均无显著交互作用(P分别为0.181、0.153、0.168、0.788)。
要点
- 精子形态作为生物标志物识别从ICSI获益更多夫妇的价值有限。
- ICSI组活产率34.6%(184/532)vs 传统IVF组31.2%(166/532)。
- 精子形态与治疗效应在四项结局上均无显著交互作用。
核心结论
- 在精子总数和活力正常的不育夫妇中,精子形态作为生物标志物识别从ICSI较传统IVF获益更多夫妇的价值有限。
研究设计与样本
- 研究为一项开放标签、多中心随机临床试验的二次分析,共纳入1064对精子总数和活力正常的不育夫妇。
主要发现
- 两组精子正常形态比例中位数均为3%(四分位距1-6%)。
- 活产率ICSI组为34.6%(184/532),传统IVF组为31.2%(166/532)。
- 精子形态与ICSI相比传统IVF的治疗效应在活产、持续妊娠、临床妊娠和完全受精失败上均无显著交互作用(P分别为0.181、0.153、0.168和0.788)。
- 限制性立方样条分析未发现精子形态与治疗效应之间存在交互作用的证据。
局限性
- 该二次分析在某些精子形态水平上事件数相对较少,可能检验效能不足,无法检测不同精子形态水平下治疗效应的差异。
- 精子形态评估在首次咨询时进行,而非在随机化当天进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Among couples with infertility and normal total sperm count and motility, can sperm morphology be used as a biomarker to identify couples who benefit more from ICSI over conventional IVF (c-IVF) on fertility outcomes? SUMMARY ANSWER: Based on this secondary analysis of a large randomized clinical trial (RCT), sperm morphology has limited value as a biomarker to identify couples who benefit more from ICSI over c-IVF on live birth, ongoing pregnancy, clinical pregnancy or total fertilization failure. WHAT IS KNOWN ALREADY: Our recent RCT showed that ICSI did not result in higher live birth rates in couples with normal total sperm count and motility. It is unclear whether sperm morphology can be used as a biomarker to identify couples who benefit more from ICSI over c-IVF in this population. STUDY DESIGN, SIZE, DURATION: This was a secondary analysis of an open-label, multi-centre, RCT comparing ICSI versus c-IVF in 1064 couples with infertility and normal total sperm count and motility. In this secondary study, we evaluated the effectiveness of ICSI over c-IVF in relation to sperm morphology. PARTICIPANTS/MATERIALS, SETTING, METHODS: Couples were eligible if they had ≤2 previous IVF/ICSI attempts, and the male partner had normal total sperm count and motility according to the fifth edition of the WHO laboratory manual for the examination and processing of human semen. Sperm morphology was measured from samples obtained during the first consultation and data for sperm morphology were available in partners of all participants in this trial. The outcomes of interest were live birth, ongoing pregnancy, clinical pregnancy, and total fertilization failure. We first conducted a logistic regression analysis with an interaction term (sperm morphology as a continuous variable by treatment (ICSI versus c-IVF)) on the four outcomes. We also used restricted cubic spline analysis to evaluate non-linear interaction and plotted the treatment effects of ICSI over c-IVF at different sperm morphology levels and the predicted probability of these outcomes in both ICSI and c-IVF groups. MAIN RESULTS AND THE ROLE OF CHANCE: The median proportion of sperm with normal morphology in both groups was 3% (Interquartile range 1-6%). Live birth rates were (184/532) 34.6% for ICSI versus (166/532) 31.2% for c-IVF. No significant interaction was found between sperm morphology and treatment effect of ICSI versus c-IVF on the rates of live birth, ongoing pregnancy, clinical pregnancy, and total fertilization failure (P = 0.181, 0.153, 0.168, and 0.788 respectively). In the analyses using restricted cubic splines, no evidence of interaction between sperm morphology and the treatment effect was found. Interaction figures showed that the treatment effect of ICSI over c-IVF at different sperm morphology levels was fluctuating around no effect line, and the predicted outcomes for the two groups were mostly overlapping at different sperm morphology levels. LIMITATIONS AND REASONS FOR CAUTION: This secondary analysis may be underpowered to detect a difference in treatment effects at different sperm morphology levels due to relatively small number of events at some sperm morphology levels. Moreover, sperm morphology assessment was performed during the first consultation, rather than on the day of randomization. WIDER IMPLICATIONS OF THE FINDINGS: In couples with infertility and normal total sperm count and motility, sperm morphology has a limited role as a biomarker to identify couples who benefit more from ICSI over c-IVF on fertility outcomes. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by My Duc Hospital, Ho Chi Minh City, Vietnam. RW was supported by an NHMRC EL Investigator Grant (GNT2009767). LNV has received speaker and conference fees from Merck, grant, speaker, conference fees from Merck Sharpe and Dohme, and speaker, conference, and scientific board fees from Ferring. TMH has received speaker fees from Merck, Merck Sharp Dohme, and Ferring. BWM reports consultancy, travel support and research funding from Merck and consultancy for Organon and Norgine. BWM holds stock from ObsEva. TRIAL REGISTRATION NUMBER: NCT03428919.
引用
- Pham TD, Dang VQ, Ho VNA, et al. Intracytoplasmic sperm injection versus conventional in vitro fertilization in infertile couples with normal total sperm count and motility: does sperm morphology matter? Hum Reprod. 2025. PMID: 39547931. doi:10.1093/humrep/deae252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。